Literature DB >> 11467772

The role of matrilysin (MMP-7) in leukaemia cell invasion.

C C Lynch1, S McDonnell.   

Abstract

The matrix metalloproteinases (MMPs) are important in tumour cell invasion and metastasis in many common cancers. However, relatively few studies have investigated the role of MMPs and their inhibitors, the tissue inhibitors of metalloproteinases (TIMPs), in leukaemia cell invasion. This study examined two leukaemia cell lines, K562 and HL-60 and showed that the K562 cell line was four times more invasive than the HL-60 cell line. The expression of MMP-2, matrilysin (MMP-7), MMP-9. TIMP-1, TIMP-2 and TIMP-3 was analysed. Both cell lines produced similar amounts of MMP-2, MMP-9 and TIMP-2. The K562 cells expressed more TIMP-1 than the HL-60 cells and neither cell line expressed TIMP-3. Interestingly, only the K562 cells expressed matrilysin suggesting a potential role for matrilysin in leukaemia cell invasion. in vitro invasion assays performed in the presence of a matrilysin blocking antibody showed a 40% reduction in invasive ability. This data suggests that matrilysin plays an important role in leukaemia cell invasion.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11467772     DOI: 10.1023/a:1010973808853

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  26 in total

Review 1.  Tissue inhibitors of metalloproteinases: evolution, structure and function.

Authors:  K Brew; D Dinakarpandian; H Nagase
Journal:  Biochim Biophys Acta       Date:  2000-03-07

Review 2.  Leukemia and the disruption of normal hematopoiesis.

Authors:  C L Sawyers; C T Denny; O N Witte
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

3.  Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin.

Authors:  C L Wilson; K J Heppner; P A Labosky; B L Hogan; L M Matrisian
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

4.  Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases.

Authors:  O A Alvarez; D F Carmichael; Y A DeClerck
Journal:  J Natl Cancer Inst       Date:  1990-04-04       Impact factor: 13.506

5.  Activation of gelatinase-tissue-inhibitors-of-metalloproteinase complexes by matrilysin.

Authors:  D C von Bredow; A E Cress; E W Howard; G T Bowden; R B Nagle
Journal:  Biochem J       Date:  1998-05-01       Impact factor: 3.857

6.  Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms.

Authors:  R L Shattuck-Brandt; L W Lamps; K J Heppner Goss; R N DuBois; L M Matrisian
Journal:  Mol Carcinog       Date:  1999-03       Impact factor: 4.784

7.  Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in reactive and neoplastic lymphoid cells.

Authors:  M Stetler-Stevenson; A Mansoor; M Lim; P Fukushima; J Kehrl; G Marti; K Ptaszynski; J Wang; W G Stetler-Stevenson
Journal:  Blood       Date:  1997-03-01       Impact factor: 22.113

8.  Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin's lymphomas.

Authors:  A E Kossakowska; D R Edwards; C Prusinkiewicz; M C Zhang; D Guo; S J Urbanski; T Grogan; L A Marquez; A Janowska-Wieczorek
Journal:  Blood       Date:  1999-09-15       Impact factor: 22.113

9.  Matrix metalloproteinases: biologic activity and clinical implications.

Authors:  A R Nelson; B Fingleton; M L Rothenberg; L M Matrisian
Journal:  J Clin Oncol       Date:  2000-03       Impact factor: 44.544

10.  Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity.

Authors:  T Murate; K Yamashita; H Ohashi; Y Kagami; K Tsushita; T Kinoshita; T Hotta; H Saito; S Yoshida; K J Mori
Journal:  Exp Hematol       Date:  1993-01       Impact factor: 3.084

View more
  3 in total

1.  The anti-invasive activity of synthetic alkaloid ethoxyfagaronine on L1210 leukemia cells is mediated by down-regulation of plasminogen activators and MT1-MMP expression and activity.

Authors:  Jérôme Devy; Farid Ouchani; Christelle Oudot; Jean Jacques Helesbeux; Enguerran Vanquelef; Stéphanie Salesse; Fanja Rabenoelina; Siana Al-Khara; Isabelle Letinois; Olivier Duval; Laurent Martiny; Emmanuelle Charpentier
Journal:  Invest New Drugs       Date:  2010-03-28       Impact factor: 3.850

2.  Interactions of thrombospondins with alpha4beta1 integrin and CD47 differentially modulate T cell behavior.

Authors:  Zhuqing Li; Maria J Calzada; John M Sipes; Jo Anne Cashel; Henry C Krutzsch; Douglas S Annis; Deane F Mosher; David D Roberts
Journal:  J Cell Biol       Date:  2002-04-29       Impact factor: 10.539

3.  Increased phosphorylation of eIF2α in chronic myeloid leukemia cells stimulates secretion of matrix modifying enzymes.

Authors:  Paulina Podszywalow-Bartnicka; Anna Cmoch; Magdalena Wolczyk; Lukasz Bugajski; Marta Tkaczyk; Michal Dadlez; Margaret Nieborowska-Skorska; Antonis E Koromilas; Tomasz Skorski; Katarzyna Piwocka
Journal:  Oncotarget       Date:  2016-11-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.